• THOSE FORCED CAN NOW SUE GOVERNMENT, PFIZER, EMPLOYERS WHO MANDATE, DUE TO INJURY

The U.S. drug regulator granted full approval Monday to the Pfizer Inc/BioNTech SE COVID-19 vaccine that earned emergency-use authorization in December, making it the first to secure such Food and Drug Administration validation as health authorities struggle to win over vaccine skeptics.

The FDA approved the two-dose vaccine for use in people over the age of 16. More than 204 million people in the United States have received the vaccine since it was given emergency authorization, based on data from Sunday.